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Since the discovery of hepatitis-associated antigen (HAA)
in 1963 its relationship to chronic liver disease has been
quite extensively researched. Cirrhosis and hepato-
carcinoma are commonly diagnosed in the Rhodesian
Black and the association between HAA and these two
liver diseases was investigated.
HAA was detected in 6,6% of cases of cirrhosis but
was not associated with any case of hepatoma. This
finding, in Rhodesian Blacks, where HAA is detected
in the sera of 2,5 - 3,6% of the normal. population, is of
considerable significance, implying that HAA (and the
serum hepatitis virus) is of little or no aetiological im-
portance.
s. Air. Med. l., 48, 1423 (1974).
Hepatitis-associated antigen (HAA, Australia antigen, or
serum hepatitis antigen) was discovered in 1963 in the
serum of an Australian aboriginal.' It can be detected in
the serum of patients with infective hepatitis, and the re-
lationship between this antigen and long-incubation hepa-
titis after blood transfusion was demonstrated by Prince.ll
Since then there has been much experimental and epi-
demiological evidence to further confirm the association
between HAA and serum hepatitis.
More recently reports have been appearing in the medical
literature dealing with the relationship between HAA and
chronic liver disease and hepatoma, based upon earlier
studies which linked cirrhosis of the liver with antecedent
infective hepatitis.
We should like to present our findings in respect of two
series of patients wi~h cirrhosis and hepatoma, both con-
ditions being extremely common in the Rhodesian Blacks
in our experience.
METHODS AND MATERIALS
The sera of 25 patients with cirrhosis and 30 patients with
hepatoma were tested for the presence of HAA, using
hyperimmune anti-Australia antigen baboon serum and
crossed-over immuno-electrophoresis. In all patients the
diagnosis of hepatoma or cirrhosis was confirmed histo·
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logically, Menghini needle biopsy of the liver being per-
formed upon each patient. Patients who were thought too
ill to undergo liver biopsy, or whose platelet count and/or
prothrombin time were outside the usually accepted safe
limits, were excluded from this study.
All patients were Blacks admitted to the University
medical wards of Harare Central Hospital, Salisbury,
during 1972 and 1973.
Of the patients with cirrhosis, which proved to be pre-
dominantly of macronodular pattern (Table I), only 2
were found to have HAA in the serum. In no patient in
whom the diagnosis of hepatoma was established on liver
biopsy could HAA be detected in the serum.
TABLE I. INCIDENCE OF HAA IN CIRRHOSIS AND
HEPATOMA IN RHODESIAN BLACKS
No. of Incidence of
Diagnosis patients positive HAA
Cirrhosis




Following a great deal of confusion regarding chronic
liver disease, it emerges that infective hepatitis may follow
essentially one of 3 courses:
1. It may resolve completely, leaving the liver un-
damaged.
2. It may persist with continued clinical and histological
evidence of hepatic inflammation. Thus there is persistence
of jaundice, or at least continued elevation of bilirubin and
SGOT levels for several months, while serial liver biopsy
shows chronic inflammatory infiltrates involving princi-
pally the portal areas, but with preservation of normal
liver architecture. Ultimately the inflammation subsides,
with no residual functional or histological change in the
liver.
3. It may progress in an aggressive manner characterised
by continued hepatitis clinically, and histological changes
occur which have been outlined by Klatskin' and De
Groote et al.: namely chronic inflammatory infiltration in-
volving the portal tracts and zones of necrosis which, unlike
typical viral hepatitis, tend to be larger and cross lobular
boundaries, either bridging adjacent portal triads and
central veins or involving whole lobules or groups of
lobules. Architecture is disturbed, with the eventual de-
development of postnecrotic (macronodular) cirrhosis.
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To such persistence of hepatic inflammation the terms
'chronic persistent hepatitis' in course (2), and 'active
chronic hepatitis' in course (3), have been applied. These
2 categories of disease have been shown to be associated
with a persistence of HAA in the serum.·
Sutnick,'· reviewing the relationship between HAA and
chronic liver disease, wrote rather provocatively: 'There is
a group of individuals who are susceptible to persistence of
an agent (HAA) which causes acute hepatitis, resulting in
chronic hepatitis and some postnecrotic cirrhosis. These
individuals and their damaged livers are also susceptible
to some other agent in the environment, either infectious
or non-infectious, which has the potential of causing
malignant hepatoma. This agent does not cause hepatoma
in the general population, but only in the susceptible in-
dividual. It may only cause the disease in those susceptible
individuals who already have chronic liver damage.' Per-
haps by so writing he has crystallised the thoughts of the
many workers who, in the past 5 years or so, have in-
vestigated the link between HAA and the development of
cirrhosis and hepatoma. Thus the literature abounds with
reports of the experiences of researchers in various coun-
tries of the world, this cumulative experience having been
extensively reviewed by Prince."
In relation to cirrhosis of the postnecrotic (posthepatitic)
type, Australia antigen has been reported in from 4 to
44% of cases in Europe and the USA:,·,·,1',,, In
Africa Maynard et al.'· found HAA in 33% of cirrhotic
patients in Uganda, while Bagshawe et al.' report HAA in
20,5% of their patients with cirrhosis in Kenya. A similar
experience emerges in relationship to hepatoma.
The results of this present study stand out IQ
sharp contrast to those of workers in Africa outside
Rhodesia. They are especially significant when one con-
siders that HAA is detected in a relatively high (2,5 - 3,6%)
proportion of normal rural Blacks and Black blood
donors." It has been suggested that this high detection
rate, compared with a European blood donor detection
rate of only 0,2%, is a consequence of infection by the
serum hepatitis virus during tattooing or cutting of the
skin as a tribal or witchdoctor ritual, both practices being
extremely common among the Rhodesian Blacks.
Hepatoma constitutes one of the most prevalent malig-
nancies encountered in Rhodesian Blacks according to
Harare Hospital records;" cirrhosis, predominantly of the
coarse postnecrotic type, is extremely common. HAA was
not detected in the serum of any patient with hepato-
carcinoma and was detected in only 2 (6,6%) patients with
cirrhosis. The Rhodesian experience, as outlined in this
article, and earlier by Swanepoel and Cruikshank," parallels
more closely the experience of workers in the USA" and
Northern Europe" than that of workers in Southern
Europe'" and Africa north of Rhodesia.
The hepatitis-associated antigen, and by implication the
serum hepatitis virus, appear to play little or no aetiologi-
cal role in the development of cirrhosis or hepatoma in
Rhodesia. Other aetiological factors must therefore be
considered. It may be that cirrhosis (upon which hepatoma
is almost invariably superimposed)' in Rhodesian Blacks
has an alcoholic aetiological basis. Prince's review article
shows that HAA has seldom been demonstrated in relation
to alcoholic cirrhosis." Many of our patients give a history
of heavy alcoholic intake over many years, in the form
usually of home-brewed beer, and the relationship of
chronic liver disease and alcoholic intake in Rhodesian
Blacks is the subject of formal study at the present time.
The theory that the carcinogen aflatoxin is important in
the genesis of hepatocarcinoma is an old and popular one.
Evidence of its aetiological relationship with hepatoma
comes largely from the Far East, but recently strong evi-
dence has been accumulating in Africa also, and Van
Rensburg-''O reported at the International Liver Conference
with special reference to Africa, held in Cape Town in
early 1973, that 'the experimental evidence for incrimi-
nating aflatoxin as the main cause of "epidemic" liver
cancer in Africa is rapidly becoming overwhelming'.
I wish to thank Professor J. G. Cruikshank in whose
laboratory serum testing for HAA was carried out, Mr D. R.
Barley of the Harare Hospital medical records office and the
Secretary, Rhodesian Ministry of Health, for permission to
publish.
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